权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

NCI NCTN-Network Lead Academic Site at UPCI

UPCI 的 NCI NCTN-网络领先学术网站

基本信息

批准号：
9024474
负责人：
ADAM M BRUFSKY
金额：
$ 85.35万
依托单位：
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
依托单位国家：
美国
项目类别：
财政年份：
2014
资助国家：
美国
起止时间：
2014-04-24 至 2019-02-28
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9024474
关键词：
Accounting Affect American American College of Surgeons Oncology Group Basic Science Cancer Burden Caring Cause of Death Cessation of life Clinical Research Clinical Treatment Clinical Trials Clinical Trials Cooperative Group Community Clinical Oncology Program Comprehensive Cancer Center Conduct Clinical Trials Cooperative Group Program Detection Development Diagnosis Early Diagnosis Early treatment Eastern Cooperative Oncology Group Education Expenditure Funding Future Gynecologic Oncology Group Heart Diseases Institute of Medicine (U.S.)Institution Lead Leadership Malignant Neoplasms Medical Multi-Institutional Clinical Trial National Clinical Trials Network National Surgical Adjuvant Breast and Bowel Project Pennsylvania Physicians Positioning Attribute Prevention Process Progress Reports Public Health Radiation Therapy Oncology Group Recommendation Research Infrastructure Research Personnel Science Site Survival Rate Translational Research United States University of Pittsburgh Cancer Institute base cancer care cancer clinical trial cancer diagnosis cancer therapy cost improved next generation programs public health relevance sound treatment trial trend

项目摘要

DESCRIPTION (provided by applicant): For more than 50 years, the NCI has supported a clinical trials infrastructure [the NCI National Clinical Trials Cooperative Group Program (CTCGP)] to conduct large-scale, clinical treatment trials across the nation. As part of its effort to take advantage of new discoveries in oncologic sciences, the NCI asked the Institute of Medicine (lOM) in 2009 to review the NCI-sponsored CTCGP. Based on the lOM review recommendations, as well as additional input received from stakeholders across the oncology community, the NCI has developed a comprehensive plan to transform the previous CTCGP that funded several separate organizations conducting cancer treatment trials into a new consolidated and integrated Program referred to as the NCI National Clinical Trials Network (NCTN). The University of Pittsburgh Cancer Institute (UPCI) has been an NCI-designated Comprehensive Cancer Center since 1990. The UPCI has led ably and participated in several NCI CTCGPs, including ECOG, NSABP, RTOG, GOG, and ACOSOG. The UPCI now plans to participate under the new NCI NCTN as a Lead Academic Site. We propose to participate in NCTN as a Network Lead Academic Participating Site with the following Specific Aims: 1. To enhance the quality off scientific and administrative leadership in the development and conduct of clinical trials across the NCTN; 2. To continue and improve our accrual to multi-center clinical trials at UPCI; To continue and improve processes for rapid activation of new trials at UPCI.

描述（由申请人提供）：50多年来，NCI一直支持临床试验基础设施[NCI国家临床试验合作组计划（CTCGP）]在全国范围内进行大规模的临床治疗试验。作为其努力的一部分，为了利用肿瘤科学中的新发现，NCI在2009年要求医学研究所（IOM）审查NCI赞助的CTCGP。根据lOM审查建议以及从肿瘤学界利益相关者收到的其他意见，NCI制定了一项全面计划，将之前资助几个独立组织进行癌症治疗试验的CTCGP转变为一个新的合并和综合计划，称为NCI国家临床试验网络（NCTN）。匹兹堡大学癌症研究所（UPCI）自1990年以来一直是NCI指定的综合癌症中心。UPCI已经领导并参与了几个NCI CTCGP，包括ECOG，NSABP，RTOG，GOG和ACOSOG。UPCI现在计划参加新的NCI NCTN作为一个领先的学术网站。我们建议参加NCTN作为网络领导学术参与网站与以下具体目标：1。提高NCTN临床试验开发和实施过程中科学和行政领导的质量; 2.继续并提高我们对多中心临床的收益继续并改进在UPCI快速启动新试验的流程。